Workflow
LBX(603883)
icon
Search documents
智通A股限售解禁一览|7月21日
智通财经网· 2025-07-21 01:04
今日具体限售解禁股情况如下: | 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 山高环能 | 000803 | 股权激励限售流通 | 127.72万 | | 岳阳兴长 | 000819 | 股权激励限售流通 | 215.25万 | | 张裕A | 000869 | 股权激励限售流通 | 203.57万 | | 申能股份 | 600642 | 股权激励限售流通 | 971.61万 | | 芭田股份 | 002170 | 股权激励限售流通 | 120万 | | 万马股份 | 002276 | 股权激励限售流通 | 261.12万 | | 川发龙蟒 | 002312 | 增发A股法人配售上市 | 1.25亿 | | 诚达药业 | 301201 | 延长限售锁定期流通 | 6155.94万 | | 茂硕电源 | 002660 | 增发A股原股东配售上市 | 8229.83万 | | 老百姓 | 603883 | 股权激励限售流通 | 19.36万 | | 珍宝岛 | 603567 | 股权激励限售流通 | 72.69万 | | 立方制药 | 0030 ...
“提振消费”政策解读:让政策红利落到老百姓心坎上腰包里
Xin Hua Ri Bao· 2025-07-18 00:00
"苏超"开赛以来,球迷和游客追随赛事足迹,跨区域流动、跨领域消费,形成"体育赛事引流、文 旅消费释放"新模式。"这场全民参与、文旅出圈的赛事,踢出了一记文化赋能经济社会发展的好 球。"省文旅厅产业发展处党支部委员、副处长任志强说,江苏各地稳稳接住"苏超""传球",推出"票根 +"优惠措施,通过历史底蕴的现代演绎、饮食文化的欢乐对垒、物产符号的创意碰撞、海洋文化的兄 弟叙事,不断激发"能玩、能逛、能体验"的文旅消费活力。 7月17日,由省委组织部、省委省级机关工委、省委"两新"工委共同打造的省级机关服务高质量发 展"先锋直播间"开通《江苏省实施提振消费专项行动若干措施》解读专场,邀请省发改委、省商务厅、 省文旅厅、省市场监管局、省体育局等部门单位相关党支部负责人走进直播间,解读政策、答疑解惑。 上半年:全省消费市场稳中有进 今年1-6月,全省实现社会消费品零售总额23949.0亿元,同比增长5.0%,全省社零总量占全国总规 模的9.8%,社零规模和净增额均为全国第一,全省消费市场呈现稳中有进的运行态势。"62条具体措施 进一步释放消费潜力,全方位扩大有效需求。"直播中,省发改委就业收入分配和消费处党支部委员、 ...
上半年人均消费支出1.4万元,老百姓把钱花哪儿了?
Jin Rong Shi Bao· 2025-07-17 08:29
上半年经济运行情况近日出炉,国家统计局同步发布了上半年居民收入和消费支出情况。 数据显示,上半年,全国居民人均可支配收入21840元,比上年同期名义增长5.3%,扣除价格因素,实际增长5.4%。分城乡看,城镇居民人均可支配收入 28844元,农村居民人均可支配收入11936元。城乡居民人均可支配收入的差距逐步缩小。农村居民收入名义增速和实际增速分别快于城镇居民1.2和1.5个 百分点,城乡居民人均可支配收入之比由上年同期的2.45降至2.42。 居民可支配收入是指居民可用于最终消费支出和储蓄的总和,也就是居民可用于自由支配的收入,包括现金收入和实物收入。居民家庭有多大的购买力主 要看居民人均可支配收入这个指标。 从中位数来看,上半年,全国居民人均可支配收入中位数18186元,增长4.8%,中位数是平均数的83.3%。其中,城镇居民人均可支配收入中位数25380 元,增长4.0%;农村居民人均可支配收入中位数10060元,增长5.5%。 注:图片来源于国家统计局网站 按照收入的来源,可支配收入包括工资性收入、经营净收入、财产净收入和转移净收入。"工资性收入、转移净收入和经营净收入较快增长,是支撑居民 收入增长的 ...
2025年人民币升值了吗?人民币升值对阵贬值,普通老百姓如何应对?
Sou Hu Cai Jing· 2025-07-15 05:52
Group 1 - The fluctuation of the RMB exchange rate in 2025 has significant implications for both individuals and businesses, with a notable appreciation against the USD observed in July, reaching 7.1656, marking a 1.82% increase since the beginning of the year [1] - The RMB's appreciation is attributed to multiple factors, including the easing of US-China trade tensions, strong domestic economic recovery, and changes in international geopolitical dynamics, which have bolstered investor confidence in RMB assets [1] - China's GDP growth continues to lead globally, with foreign exchange reserves remaining above $3.2 trillion for five consecutive months, providing a solid foundation for the RMB exchange rate [1] Group 2 - The short-term benefits of RMB appreciation include reduced costs for overseas travel, education, and imported goods, with examples showing a decrease in the cost of a trip to the US from 50,000 yuan to 40,000 yuan and lower prices for imported cars [3] - However, long-term effects of RMB appreciation may negatively impact export-oriented businesses, leading to reduced profit margins, such as a drop in profit margin from 5% to 2% for a clothing factory, and potential capital outflows if companies do not hedge against exchange rate risks [3] - In contrast, RMB depreciation can increase costs for overseas travel and education, with a 20% rise in outbound travel costs noted during a previous depreciation, while simultaneously enhancing the international competitiveness of Chinese exports [5] Group 3 - To navigate the volatility of the RMB exchange rate, individuals planning to travel abroad are advised to avoid impulsive currency exchanges and consider a phased approach to mitigate risks, similar to dollar-cost averaging in investments [6] - Investors holding USD assets should not rush to sell, as the value of these assets may increase during RMB depreciation, but they should remain vigilant about the impact of US inflation on the dollar's value [6] - Companies in sectors that benefit from RMB appreciation, such as airlines and industries heavily reliant on imports, may present investment opportunities as their costs decrease [6]
为老百姓办更多实事(党旗在基层一线高高飘扬)
Ren Min Ri Bao· 2025-07-10 22:52
Core Insights - The article highlights the successful transformation of Nanliunan Village's economy through agricultural development and community organization led by Yu Bianqing, the village's first secretary [2][3][6]. Group 1: Agricultural Development - Yu Bianqing introduced new fruit varieties such as Yuluo Xiang Pear, Cherry, and Bai Shui Apricot to revive the village's fruit industry after previous failures due to soil diseases [3]. - The village's fruit orchard began to bear fruit in 2021, but initial sales were challenging, prompting Yu to explore new marketing strategies including live streaming and short videos [3][5]. - A significant sales event at a local agricultural exhibition resulted in the sale of 1,500 boxes of Bai Shui Apricot, indicating strong market demand [5]. Group 2: Community Organization and Support - Yu emphasized the importance of community cohesion, leading to the establishment of a support group for sales and logistics, which included local farmers and party members [5]. - The village's collective efforts have led to the development of a cooperative that provides services such as cold storage, packaging, and processing for fruit products across six administrative villages [6]. - The introduction of a comprehensive agricultural project combining organic vegetable farming and tourism is underway, aiming to enhance the village's economic resilience [6].
新店扩张成利润黑洞,老百姓规模效应难以为继,控股股东减持与质押狂欢
Sou Hu Cai Jing· 2025-07-09 02:18
今年5月6日,老百姓(603883.SH)控股股东老百姓医药集团有限公司(以下简称"医药集团")抛出一份减持 计划,高调宣称"减持原因之一为降质押率"。一个月后,医药集团就将其所持上市公司的1235万股股份 进行了质押,6月27日更是上演"解押再质押"滚动融资戏码。不仅与承诺背道而驰,老百姓控股股东的 质押比例也推高至62.04%。 证券之星注意到,蹊跷的是,医药集团抛出减持计划前夕,老百姓正遭遇上市以来最差成绩单:2024年 营利双降,归母净利润暴跌四成之多。去年以来,在消费力下行、市场竞争加剧及监管力度加强等多重 因素叠加下,大量药房出现了不同程度的下滑甚至亏损。行业原因之外,新店扩张成了老百姓的"利润 黑洞"。 当单纯依靠门店扩张的粗放模式难以为继,业绩重压下的老百姓,开始寻求向老店转加盟为主以及DTP 药房的模式转变。老百姓能否熬过行业寒冬,穿越周期有待验证。 大股东左手减持降质押率,右手"还旧借新" 2025年6月27日,医药集团将其持有老百姓的3211万股股份质押给中国建设银行股份有限公司长沙湘江 支行(以下简称"建设银行湘江支行"),质押期限三年(至2028年6月30日),资金用途为"自身生产经 ...
老百姓大药房连锁股份有限公司2024年年度权益分派实施公告
Core Points - The company announced a cash dividend distribution of 0.08 yuan per share for the fiscal year 2024, approved at the shareholders' meeting on June 30, 2025 [2][4] - The total cash dividend to be distributed amounts to approximately 60.81 million yuan, based on a total share capital of 760,095,613 shares [4] - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [3] Distribution Plan - The cash dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited, with shareholders who have completed designated transactions able to receive their dividends on the payment date [5] - The distribution does not involve the issuance of bonus shares or capital increases [6] - Direct cash dividends will be issued to specific shareholders, including Lao Bai Xing Medical Group Co., Ltd., Zexing Investment Co., Ltd., and Chen Xiulan [9] Taxation Details - For individual shareholders and securities investment funds holding unrestricted circulating shares, no income tax will be withheld at the time of dividend distribution, with the actual cash dividend being 0.08 yuan per share [10] - Tax liabilities will be calculated based on the holding period of the shares, with different tax rates applicable: 20% for holdings of one month or less, 10% for holdings between one month and one year, and no tax for holdings over one year [10] - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.072 yuan per share [11]
老百姓(603883) - 2024年年度权益分派实施公告
2025-07-07 10:30
证券代码:603883 证券简称:老百姓 公告编号:2025-034 老百姓大药房连锁股份有限公司 2024年年度权益分派实施公告 A 股每股现金红利0.08元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2025/7/11 | - | 2025/7/14 | 2025/7/14 | 差异化分红送转: 否 一、 通过分配方案的股东大会届次和日期 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例 3. 分配方案: 三、 相关日期 本次利润分配方案经公司2025 年 6 月 30 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 本次利润分配以方案实施前的公司总股本760,095,613股为基数,每股派发现金红利0.08 元(含 ...
刺激老百姓买房,湖北多地接连放大招
Sou Hu Cai Jing· 2025-07-07 01:05
Group 1 - Recent policies in Hubei province include lowering mortgage down payments to 15%, direct housing subsidies, and flexible use of public housing funds [2][3] - The city of Tianmen serves as a model, having implemented substantial housing subsidies and birth incentives, resulting in a significant increase in birth rates [3][4][8] - Tianmen's success demonstrates that financial incentives can effectively stimulate consumption and birth rates, prompting other cities in Hubei to adopt similar strategies [4][8][17] Group 2 - Hubei's financial capacity supports these initiatives, with a public budget revenue of 393.7 billion yuan in 2023, ranking 11th nationally [7] - The province's population structure is relatively healthy, with over 58 million residents, allowing for effective policy implementation [7][8] - The policies aim to reduce living costs and enhance consumer spending power, addressing the economic challenges posed by declining population dividends and consumption downgrades [11][16] Group 3 - The approach taken by Hubei is seen as a shift towards prioritizing citizen welfare over mere GDP growth, indicating a change in governance philosophy [21][22] - The success of Tianmen's policies, including a birth rate increase to 6.77‰ and a rise in housing sales, serves as evidence that direct financial support can revitalize the economy [14][17] - Hubei's actions provide a template for other regions, emphasizing the importance of substantial financial incentives to stimulate economic activity [22][23]
老百姓大药房连续四年荣膺“中国卓越管理公司(BMC)”奖项
Zheng Quan Ri Bao Wang· 2025-07-04 10:48
Core Insights - The company "老百姓大药房连锁股份有限公司" has been awarded the title of "Best Managed Company" (BMC) in China for the fourth consecutive year, highlighting its excellence in management practices [1] - The BMC project, established in Canada in 1993, evaluates companies based on advanced management concepts and sustainable development, with 75 companies recognized this year, collectively generating revenues of 3.2 trillion yuan [1][2] - The company has been proactive in digital transformation, investing in smart technology to enhance operational efficiency and customer satisfaction, with a planned R&D investment of 136 million yuan in 2024, representing 0.6% of its total revenue [2] Company Strategy and Innovation - The company has established an AI Application Strategy Committee to oversee its AI initiatives, with a focus on integrating AI across various business functions to improve efficiency and marketing strategies [3] - It has developed multiple generative AI dialogue assistants to support business operations, leveraging its extensive data assets and industry knowledge [3] - The company aims to maintain a forward-looking strategy to meet evolving customer health needs while promoting sustainable development and contributing to the health of the nation [3]